Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

39 structures for P29084

Entry ID Method Resolution Chain Position Source
1D8J NMR - A 66-146 PDB
1D8K NMR - A 66-146 PDB
5GPY X-ray 210 A B 141-244 PDB
5IY6 EM 720 A R 1-291 PDB
5IY7 EM 860 A R 1-291 PDB
5IY8 EM 790 A R 1-291 PDB
5IY9 EM 630 A R 1-291 PDB
5IYA EM 540 A R 1-291 PDB
5IYB EM 390 A R 1-291 PDB
5IYC EM 390 A R 1-291 PDB
5IYD EM 390 A R 1-291 PDB
6O9L EM 720 A R 1-291 PDB
7EG9 EM 370 A V 1-291 PDB
7EGA EM 410 A V 1-291 PDB
7EGB EM 330 A V 1-291 PDB
7EGC EM 390 A V 1-291 PDB
7ENA EM 407 A EB 1-291 PDB
7ENC EM 413 A EB 1-291 PDB
7LBM EM 480 A R 1-291 PDB
7NVR EM 450 A X 1-291 PDB
7NVS EM 280 A X 1-291 PDB
7NVT EM 290 A X 1-291 PDB
7NVU EM 250 A X 1-291 PDB
7NVY EM 730 A X 1-291 PDB
7NVZ EM 720 A X 1-291 PDB
7NW0 EM 660 A X 1-291 PDB
8BVW EM 400 A X 1-291 PDB
8BYQ EM 410 A X 1-291 PDB
8GXQ EM 504 A EB 1-291 PDB
8GXS EM 416 A EB 1-291 PDB
8WAK EM 547 A V 1-291 PDB
8WAL EM 852 A V 1-291 PDB
8WAN EM 607 A V 1-291 PDB
8WAO EM 640 A V 1-291 PDB
8WAP EM 585 A V 1-291 PDB
8WAQ EM 629 A V 1-291 PDB
8WAR EM 720 A V 1-291 PDB
8WAS EM 613 A V 1-291 PDB
AF-P29084-F1 Predicted AlphaFoldDB

204 variants for P29084

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV003166658
RCV001297111
CA4701109
rs141148292
25 R>C Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA10576099
VAR_076893
rs875989846
RCV000211060
150 A>P Trichothiodystrophy 6, nonphotosensitive TTD6; reduction in the levels of both TFIIE-alpha and TFIIE-beta subunits of the TFIIE complex in patient cells; reduced phosphorylation of TFIIE-alpha observed in patient cells [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV000211077
rs875989847
VAR_076894
CA10576100
187 D>Y Trichothiodystrophy 6, nonphotosensitive TTD6; reduction in the levels of both TFIIE-alpha and TFIIE-beta subunits of the TFIIE complex in patient cells; reduced phosphorylation of TFIIE-alpha observed in patient cells [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
CA4701120
rs367818718
2 D>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4701119
rs752353931
3 P>S No ClinGen
ExAC
gnomAD
CA4701118
rs752353931
3 P>T No ClinGen
ExAC
gnomAD
rs766224944
CA174442348
13 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA4701114
rs766224944
13 K>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 14 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs763006801
CA4701113
15 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
CA174442341
rs776927046
15 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4701112
rs750341340
20 P>A No ClinGen
ExAC
gnomAD
rs1301552428
CA370877574
21 V>A No ClinGen
gnomAD
CA4701111
rs144991013
21 V>L No ClinGen
ESP
ExAC
CA4701110
rs761618380
22 V>A No ClinGen
ExAC
gnomAD
CA174442303
rs759602974
23 E>G No ClinGen
TOPMed
CA4701108
rs191911969
25 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA174442283
rs191911969
25 R>P No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs759605279
CA4701107
26 S>L No ClinGen
ExAC
gnomAD
CA370877473
rs1188374092
28 S>T No ClinGen
gnomAD
rs774545618
CA4701106
31 S>L No ClinGen
ExAC
gnomAD
CA4701105
rs372189467
33 S>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1331023288
CA370877403
33 S>P No ClinGen
TOPMed
CA174442252
rs953524794
35 S>L No ClinGen
TOPMed
gnomAD
CA174442259
rs773425049
35 S>T No ClinGen
TOPMed
RCV001315703
rs572162637
36 S>missing No ClinVar
dbSNP
rs4620241
CA174442241
36 S>A No ClinGen
Ensembl
TCGA novel 37 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1187558758
CA370877318
37 K>R No ClinGen
TOPMed
CA370877302
rs1586013896
38 K>E No ClinGen
Ensembl
rs778170587
CA4701102
38 K>R No ClinGen
ExAC
gnomAD
CA370877265
rs1413140154
39 K>N No ClinGen
TOPMed
TCGA novel 41 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4701100
rs770238678
41 T>R No ClinGen
ExAC
gnomAD
rs780963948
CA4701098
42 K>Q No ClinGen
ExAC
gnomAD
CA370877156
rs1563513580
45 H>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA4701095
rs543436891
46 G>A No ClinGen
1000Genomes
ExAC
gnomAD
CA4701096
rs543436891
46 G>E No ClinGen
1000Genomes
ExAC
gnomAD
CA4701094
rs139563701
47 G>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1467032947
CA370877141
47 G>R No ClinGen
TOPMed
rs1164030994
CA370877125
48 S>L No ClinGen
TOPMed
gnomAD
rs771803770
CA4701093
48 S>P No ClinGen
ExAC
TOPMed
gnomAD
CA370877126
rs1164030994
48 S>W No ClinGen
TOPMed
gnomAD
CA4701091
rs761565129
49 S>* No ClinGen
ExAC
TOPMed
CA370877117
rs761565129
49 S>L No ClinGen
ExAC
TOPMed
rs1306050009
CA370877105
50 G>D No ClinGen
TOPMed
rs368009804
CA4701090
51 S>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 52 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA370877074
rs1443949751
53 Q>E No ClinGen
gnomAD
rs909336835
CA174442175
55 S>C No ClinGen
TOPMed
gnomAD
rs1238640146
CA370877030
55 S>P No ClinGen
gnomAD
rs1490225393
CA370885620
56 D>E No ClinGen
gnomAD
CA370885625
rs1372670414
56 D>G No ClinGen
TOPMed
rs752479061
CA4701048
57 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs766622922
CA4701047
58 S>C No ClinGen
ExAC
gnomAD
rs758609060
CA4701046
58 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs995836553
CA174452685
59 N>S No ClinGen
TOPMed
CA4701044
rs115460759
62 F>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA370885457
rs1221291165
66 A>D No ClinGen
gnomAD
CA174452681
rs879790610
66 A>S No ClinGen
TOPMed
rs879790610
CA370885460
66 A>T No ClinGen
TOPMed
rs754348956
CA4701042
67 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs1299728093
CA370885431
68 S>P No ClinGen
TOPMed
gnomAD
rs913677259
CA174452675
71 S>C No ClinGen
TOPMed
gnomAD
rs966306118
CA174452670
72 G>R No ClinGen
TOPMed
CA174452666
rs202060134
73 Y>C No ClinGen
1000Genomes
CA370885286
rs1383470487
76 G>V No ClinGen
gnomAD
CA370885262
COSM3834572
rs1184814347
78 L>V breast [Cosmic] No ClinGen
cosmic curated
TOPMed
rs775773322
CA4701039
80 K>M No ClinGen
ExAC
TOPMed
gnomAD
rs775773322
CA4701040
80 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs775773322
CA370885239
80 K>T No ClinGen
ExAC
TOPMed
gnomAD
rs1383823247
CA370885222
81 I>M No ClinGen
TOPMed
CA4701038
rs772498106
81 I>S No ClinGen
ExAC
gnomAD
rs986411536
CA174452659
81 I>V No ClinGen
TOPMed
gnomAD
rs1480238531
CA370885153
85 M>R No ClinGen
gnomAD
CA4701037
rs759040162
85 M>V No ClinGen
ExAC
gnomAD
rs774020566
CA4701036
86 K>Q No ClinGen
ExAC
gnomAD
rs533926333
CA4701013
88 R>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA370881460
rs892994715
89 H>L No ClinGen
TOPMed
gnomAD
CA174448111
rs892994715
89 H>R No ClinGen
TOPMed
gnomAD
CA174448113
rs971896773
89 H>Y No ClinGen
TOPMed
rs779271698
CA4701010
90 Q>R No ClinGen
ExAC
gnomAD
rs754124140
CA4701008
91 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
COSM1241236
rs1024658169
RCV001340310
CA174448103
91 R>Q oesophagus [Cosmic] No ClinGen
cosmic curated
ClinVar
TOPMed
dbSNP
gnomAD
CA4701007
RCV001296699
rs777646389
93 D>N No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
TCGA novel
CA370881388
rs1585966569
94 T>M Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
Ensembl
rs1220007935
CA370881378
95 H>Y No ClinGen
TOPMed
CA370881302
rs1316970312
100 D>G No ClinGen
TOPMed
CA4701004
rs114292437
100 D>Y No ClinGen
1000Genomes
ExAC
gnomAD
CA370881201
rs1210100334
105 E>G No ClinGen
TOPMed
CA4701001
rs766007320
108 H>L No ClinGen
ExAC
gnomAD
TCGA novel 108 H>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4701000
rs762536890
110 D>G No ClinGen
ExAC
gnomAD
CA370881131
rs1290266796
110 D>N No ClinGen
gnomAD
CA370881126
rs1290266796
110 D>Y No ClinGen
gnomAD
CA4700999
rs772924568
115 Q>P No ClinGen
ExAC
gnomAD
rs1449671508
CA370881015
118 W>G No ClinGen
TOPMed
CA370880963
rs1220474490
120 M>I No ClinGen
TOPMed
CA4700997
rs555065014
120 M>L No ClinGen
1000Genomes
ExAC
gnomAD
CA370880959
rs1263902806
121 T>A No ClinGen
TOPMed
CA4700996
COSM1099108
rs776412409
121 T>I Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs749996086
CA4700978
124 L>F No ClinGen
ExAC
gnomAD
CA4700977
rs764989549
126 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA174447632
rs956064278
127 N>S No ClinGen
TOPMed
gnomAD
rs1320180200
COSM1456608
CA370879768
129 K>R Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA4700975
rs776261279
130 I>M No ClinGen
ExAC
gnomAD
TCGA novel 130 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4700974
rs763708188
132 V>I No ClinGen
ExAC
TOPMed
gnomAD
VAR_052281
RCV001316956
CA4700973
rs2229299
133 I>T No ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1172858224
CA370879711
133 I>V No ClinGen
gnomAD
rs775599789
CA4700972
135 G>R No ClinGen
ExAC
gnomAD
rs771941105
CA4700971
138 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA370879545
rs368609280
144 N>I No ClinGen
ESP
TOPMed
CA174447623
rs368609280
144 N>S No ClinGen
ESP
TOPMed
rs369822113
CA370879536
145 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
RCV001326429
rs369822113
CA4700969
145 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs868665063
CA174447619
147 D>Y No ClinGen
Ensembl
CA370879446
rs1279803659
150 A>G No ClinGen
gnomAD
COSM1193596
rs747477737
CA4700964
158 H>R lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA4700965
rs755060053
158 H>Y No ClinGen
ExAC
gnomAD
CA4700962
rs375279264
162 G>R No ClinGen
ESP
ExAC
gnomAD
TCGA novel 165 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 167 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1470806625
CA370879193
170 D>N No ClinGen
gnomAD
CA370879070
rs1421012068
177 N>H No ClinGen
gnomAD
CA4700958
rs753435715
177 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1563487218
CA370879029
178 S>F No ClinGen
Ensembl
rs1183381113
CA370878976
182 V>I No ClinGen
TOPMed
gnomAD
rs760282859
CA4700956
COSM1099105
183 K>E Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs2978277
RCV001346806
183 K>M No ClinVar
dbSNP
CA4700955
rs2978277
VAR_039003
RCV000888459
183 K>R No ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1357122776
CA370878301
184 A>G No ClinGen
gnomAD
CA4700923
rs775606486
189 I>L No ClinGen
ExAC
gnomAD
rs1440885920
CA370878181
192 V>I No ClinGen
gnomAD
rs772048330
CA4700922
193 N>S No ClinGen
ExAC
rs749607324
COSM1673830
CA174446409
194 R>C Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs527328234
COSM605373
CA4700921
194 R>H lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA370878121
rs1423308029
195 P>R No ClinGen
gnomAD
CA370878129
rs1404473383
195 P>S No ClinGen
TOPMed
CA4700919
COSM3779181
rs780571452
196 D>N Variant assessed as Somatic; 0.0 impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA4700918
rs749706627
197 K>E No ClinGen
ExAC
gnomAD
rs146320824
CA4700917
197 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 199 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA370878062
rs1563484223
199 K>Q No ClinGen
Ensembl
rs1176833728
CA370878046
200 I>L No ClinGen
TOPMed
gnomAD
rs1176833728
CA370878043
200 I>V No ClinGen
TOPMed
gnomAD
CA370877940
rs1271160778
203 F>L No ClinGen
TOPMed
gnomAD
rs138879441
CA4700916
204 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA370877883
rs1489849157
205 D>G No ClinGen
gnomAD
rs747813242
CA4700915
206 K>R No ClinGen
ExAC
gnomAD
CA370877824
rs1414233558
207 S>G No ClinGen
TOPMed
gnomAD
CA4700914
rs780689146
208 C>S No ClinGen
ExAC
gnomAD
CA4700913
rs754481192
208 C>W No ClinGen
ExAC
gnomAD
rs747764482
CA4700895
215 E>G No ClinGen
ExAC
gnomAD
rs1380066288
CA370877639
215 E>Q No ClinGen
gnomAD
rs936676754
CA174433918
216 F>L No ClinGen
TOPMed
CA4700893
rs754492883
220 W>* No ClinGen
ExAC
rs866292344
CA174433905
221 R>K No ClinGen
Ensembl
CA4700892
rs746541899
224 T>A No ClinGen
ExAC
gnomAD
CA370875137
rs1469413175
224 T>S No ClinGen
gnomAD
rs1373700874
CA370875116
227 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA4700891
rs780037889
228 M>T No ClinGen
ExAC
gnomAD
rs1275069225
CA370875106
229 D>H No ClinGen
TOPMed
CA4700889
rs764969255
230 E>* No ClinGen
ExAC
gnomAD
CA4700888
rs764969255
230 E>K No ClinGen
ExAC
gnomAD
CA4700887
rs757065013
230 E>V No ClinGen
ExAC
gnomAD
rs752941531
CA4700886
233 I>T No ClinGen
ExAC
gnomAD
CA174433874
rs4923
234 E>K No ClinGen
Ensembl
CA370875052
rs1244666467
236 Y>F No ClinGen
gnomAD
rs1343778122
CA370875040
238 K>R No ClinGen
gnomAD
TCGA novel 239 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748268212
CA4700884
239 R>Q No ClinGen
ExAC
gnomAD
rs945410284
CA174433862
240 Q>E No ClinGen
TOPMed
gnomAD
CA4700883
rs370220215
244 S>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4700882
rs375607570
245 M>L No ClinGen
ESP
ExAC
gnomAD
rs773888848
CA174433851
250 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs773888848
CA4700880
250 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA370874887
rs1303776324
254 A>D No ClinGen
gnomAD
CA370874888
rs1303776324
254 A>G No ClinGen
gnomAD
rs1232942032
CA370874881
255 P>R No ClinGen
TOPMed
gnomAD
CA4700858
rs776919336
256 I>V No ClinGen
ExAC
gnomAD
rs1158011803
CA370874847
260 K>R No ClinGen
TOPMed
CA4700857
rs769080148
262 P>T No ClinGen
ExAC
gnomAD
CA4700856
rs760180975
263 A>V No ClinGen
ExAC
gnomAD
rs1585926651
CA918231683
264 S>* No ClinGen
Ensembl
CA370874813
rs1364054518
265 Q>H No ClinGen
gnomAD
rs571887654
CA4700855
268 R>Q No ClinGen
1000Genomes
ExAC
gnomAD
CA370874789
rs1416848056
269 R>C No ClinGen
TOPMed
gnomAD
rs150253885
CA4700853
269 R>H Variant assessed as Somatic; 0.0004157 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs150253885
CA370874787
269 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4700852
rs778817965
272 T>S No ClinGen
ExAC
gnomAD
rs770909330
CA4700851
273 H>N No ClinGen
ExAC
gnomAD
COSM3432340
rs1209670862
CA370874748
275 E>K Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA4700849
rs777361051
278 A>S No ClinGen
ExAC
gnomAD
rs755966155
CA4700848
280 V>A No ClinGen
ExAC
gnomAD
CA4700847
rs141953164
282 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA370874703
rs141953164
282 K>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4700846
rs758525253
285 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs758525253
CA4700845
285 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs201933370
CA174433060
286 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs932072354
CA174433044
287 I>V No ClinGen
TOPMed
gnomAD
rs1347377549
CA370874663
288 T>S No ClinGen
TOPMed
gnomAD
rs751070215
CA4700843
289 S>C No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 291 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA

1 associated diseases with P29084

[MIM: 616943]: Trichothiodystrophy 6, non-photosensitive (TTD6)

A form of trichothiodystrophy, a disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non-photosensitive forms of the disorder. TTD6 patients do not manifest cutaneous photosensitivity. Inheritance pattern has been reported to be autosomal recessive. {ECO:0000269|PubMed:26996949}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of trichothiodystrophy, a disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non-photosensitive forms of the disorder. TTD6 patients do not manifest cutaneous photosensitivity. Inheritance pattern has been reported to be autosomal recessive. {ECO:0000269|PubMed:26996949}. Note=The disease is caused by variants affecting the gene represented in this entry.

2 regional properties for P29084

Type Name Position InterPro Accession
domain Transcription factor TFIIE beta subunit, DNA-binding domain 66 - 146 IPR003166
domain TFA2, Winged helix domain 2 146 - 204 IPR040501

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
transcription factor TFIID complex A complex composed of TATA binding protein (TBP) and TBP associated factors (TAFs); the total mass is typically about 800 kDa. Most of the TAFs are conserved across species. In TATA-containing promoters for RNA polymerase II (Pol II), TFIID is believed to recognize at least two distinct elements, the TATA element and a downstream promoter element. TFIID is also involved in recognition of TATA-less Pol II promoters. Binding of TFIID to DNA is necessary but not sufficient for transcription initiation from most RNA polymerase II promoters.
transcription factor TFIIE complex A transcription factor which in humans consists of a complex of two alpha and two beta chains. Recruits TFIIH to the initiation complex and helps activate both RNA polymerase II and TFIIH.

3 GO annotations of molecular function

Name Definition
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
RNA binding Binding to an RNA molecule or a portion thereof.
RNA polymerase II general transcription initiation factor activity A general transcription initiation factor activity that contributes to transcription start site selection and transcription initiation of genes transcribed by RNA polymerase II. The general transcription factors for RNA polymerase II include TFIIB, TFIID, TFIIE, TFIIF, TFIIH and TATA-binding protein (TBP). In most species, RNA polymerase II transcribes all messenger RNAs (mRNAs), most untranslated regulatory RNAs, the majority of the snoRNAs, four of the five snRNAs (U1, U2, U4, and U5), and other small noncoding RNAs. For some small RNAs there is variability between species as to whether it is transcribed by RNA polymerase II or RNA polymerase III. However there are also rare exceptions, such as Trypanosoma brucei, where RNA polymerase I transcribes certain mRNAs in addition to its normal role in rRNA transcription.

2 GO annotations of biological process

Name Definition
transcription by RNA polymerase II The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
transcription initiation at RNA polymerase II promoter A transcription initiation process that takes place at a RNA polymerase II gene promoter. Messenger RNAs (mRNA) genes, as well as some non-coding RNAs, are transcribed by RNA polymerase II.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P36145 TFA2 Transcription initiation factor IIE subunit beta Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
10 20 30 40 50 60
MDPSLLRERE LFKKRALSTP VVEKRSASSE SSSSSSKKKK TKVEHGGSSG SKQNSDHSNG
70 80 90 100 110 120
SFNLKALSGS SGYKFGVLAK IVNYMKTRHQ RGDTHPLTLD EILDETQHLD IGLKQKQWLM
130 140 150 160 170 180
TEALVNNPKI EVIDGKYAFK PKYNVRDKKA LLRLLDQHDQ RGLGGILLED IEEALPNSQK
190 200 210 220 230 240
AVKALGDQIL FVNRPDKKKI LFFNDKSCQF SVDEEFQKLW RSVTVDSMDE EKIEEYLKRQ
250 260 270 280 290
GISSMQESGP KKVAPIQRRK KPASQKKRRF KTHNEHLAGV LKDYSDITSS K